EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients

Hayeon Kim, Hyo Jung Kim, Yang Tae Park, Jae Seon Kim

Journal of Gastrointestinal and Liver Diseases · 2023

DOI: 10.15403/jgld-4841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2023. Verfasst von Hayeon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. . hjkimmaria@gmail.com. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: In biliary epithelial cells, two bile acid receptors, sphingosine 1-phosphate receptor 2 (S1PR2) and Takeda G protein-coupled receptor 5 (TGR5) have been reported to trigger cell proliferation, as well as neoplastic cell invasiveness. In this study, we aimed to investigate the clinical significance of S1PR2/ TGR5 expression in extrahepatic cholangiocarcinoma (CCA) patients.

Methods

Patients who underwent surgical resection of extrahepatic CCA at Korea University Guro Hospital between 2002 and 2018 were included. Data on immunohistochemical staining and H-score of S1PR2 and TGR5 were evaluated using digital image analysis.

Results

A total of 115 cases of invasive CCA were analyzed. The H-score of S1PR2 showed a decrease in invasive CCA (p=0.052) but that of TGR5 showed a significant increase (p=0.02). Overall survival and disease-free survival were significantly lower in the low S1PR2 expression group (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsCholangiocarcinomaHumansSphingosine-1-Phosphate ReceptorsClinical RelevanceReceptors, G-Protein-CoupledBile Ducts, Intrahepatic

Substanzen

Sphingosine-1-Phosphate ReceptorsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. . hjkimmaria@gmail.com.
  • Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. . hjkimmd@korea.ac.kr.
  • Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. cleophe@naver.com.
  • Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. leeseoungjae0917@gmail.com.

Zitieren

APA

Kim, H., Kim, H. J., Park, Y. T., & Kim, J. S. (2023). Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-4841

Vancouver

Kim H, Kim HJ, Park YT, Kim JS. Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients. Journal of Gastrointestinal and Liver Diseases. 2023. doi:10.15403/jgld-4841

BibTeX
@article{Kim2023,
  author = {Kim, Hayeon and Kim, Hyo Jung and Park, Yang Tae and Kim, Jae Seon},
  title = {Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2023},
  doi = {10.15403/jgld-4841}
}
Kostenlos starten →